Surveillance endoscopy in the management of hereditary diffuse gastric cancer syndrome Research Letter


Authors: Friedman, M.; Adar, T.; Patel, D.; Lauwers, G. Y.; Yoon, S. S.; Mullen, J. T.; Chung, D. C.
Title: Surveillance endoscopy in the management of hereditary diffuse gastric cancer syndrome
Abstract: Hereditary diffuse gastric cancer (HDGC) syndrome results from a germline CDH1 mutation, and microscopic foci of signet-ring carcinoma cells (SRCC) are present in nearly all gastrectomy specimens.1 The lifetime risk of invasive gastric cancer (GC) has been thought to be 70%,2 but recent data have suggested a lower risk of 37%.3 Prophylactic total gastrectomy is considered the standard of care, but many patients choose surveillance endoscopy instead. We sought to define the outcomes in CDH1-positive individuals who pursued endoscopic surveillance. © 2021 AGA Institute
Journal Title: Clinical Gastroenterology and Hepatology
Volume: 19
Issue: 1
ISSN: 1542-3565
Publisher: Elsevier Science, Inc.  
Date Published: 2021-01-01
Start Page: 189
End Page: 191
Language: English
DOI: 10.1016/j.cgh.2019.10.033
PUBMED: 31678201
PROVIDER: scopus
DOI/URL:
Notes: Short Survey -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sam Yoon
    108 Yoon